Clin2
NCT07694635Possibly a fitNot yet recruiting

Predicting bilirubin rebound after phototherapy in newborns

Neonatal HyperbilirubinemiaRebound Hyperbilirubinemia

Part of Genetic & congenital clinical trials.

This study looks at what happens to a newborn's bilirubin level (the substance that causes jaundice) in the 48 hours after light therapy (phototherapy) is stopped, to see if it goes back up. It aims to help predict which babies might need more treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
2 hours to 4 weeks
Study type
Observational

Who can take part

  • Your baby must be at least 35 weeks along at birth.
  • Your baby must have jaundice that needs treatment with light therapy (phototherapy).
  • Your baby's bilirubin levels must be measured before, during, and after light therapy.
  • Your baby must have a follow-up bilirubin test within 48 hours after light therapy stops.
  • Your baby cannot have certain severe health conditions, like major birth defects, liver disease, or metabolic disorders.
  • Your baby cannot have needed a blood exchange transfusion before the first round of light therapy finishes.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07761689Recruiting
Kangaroo care for pain relief during newborn jaundice light therapy

This study tests whether holding your baby skin-to-skin (kangaroo care) during light therapy for jaundice can help reduce their pain and discomfort. It aims to see if this simple comfort measure is beneficial.

Istanbul
NCT06702241Recruiting· Phase 2/Phase 3
Light therapy for newborn jaundice

This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.

Aalborg
NCT04218318Recruiting
Stopping light therapy early in newborns with blood breakdown

This study looks for a safe threshold to stop the “light therapy” (phototherapy) in newborns who have jaundice caused by blood cell breakdown (hemolytic disease). It may help some babies avoid unnecessary extra days of treatment while still staying safe.

Madinah
NCT07674537Not yet recruiting
Jaundice treatment thresholds for very premature babies

This study looks at how hospitals decide when to start treatment for jaundice (a yellowing of the skin) in very premature babies. The aim is to find the safest and most effective way to use bilirubin levels to guide care and improve outcomes for your baby.

Groningen, Provincie Groningen
NCT07150494Not yet recruiting
A new score to assess jaundice severity in newborns

This study is looking at a new scoring system to help doctors quickly tell how severe jaundice is in newborns. The goal is to better decide when a baby needs stronger treatment like a blood exchange, so the right care can be given sooner.

NCT07610811Recruiting
Foot Reflexology and Massage for Jaundiced Newborns

This study tests whether gentle foot reflexology and massage can help newborns with jaundice (high bilirubin levels in the blood) recover faster during light therapy treatment. Jaundice is common in newborns and is usually treated with special lights; this trial explores whether touch therapy might improve outcomes.

Kusadasi, Aydın

Hear when a new Neonatal Hyperbilirubinemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.